FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3015256585> ?p ?o ?g. }

• W3015256585 endingPage "1566" @default.
• W3015256585 startingPage "1561" @default.
• W3015256585 abstract "Background & AimsSome patients with SARS-CoV-2 infection have abnormal liver function. We aimed to clarify the features of COVID-19-related liver damage to provide references for clinical treatment.MethodsWe performed a retrospective, single-center study of 148 consecutive patients with confirmed COVID-19 (73 female, 75 male; mean age, 50 years) at the Shanghai Public Health Clinical Center from January 20 through January 31, 2020. Patient outcomes were followed until February 19, 2020. Patients were analyzed for clinical features, laboratory parameters (including liver function tests), medications, and length of hospital stay. Abnormal liver function was defined as increased levels of alanine and aspartate aminotransferase, gamma glutamyltransferase, alkaline phosphatase, and total bilirubin.ResultsFifty-five patients (37.2%) had abnormal liver function at hospital admission; 14.5% of these patients had high fever (14.5%), compared with 4.3% of patients with normal liver function (P = .027). Patients with abnormal liver function were more likely to be male, and had higher levels of procalcitonin and C-reactive protein. There was no statistical difference between groups in medications taken before hospitalization; a significantly higher proportion of patients with abnormal liver function (57.8%) had received lopinavir/ritonavir after admission compared to patients with normal liver function (31.3%). Patients with abnormal liver function had longer mean hospital stays (15.09 ± 4.79 days) than patients with normal liver function (12.76 ± 4.14 days) (P = .021).ConclusionsMore than one third of patients admitted to the hospital with SARS-CoV-2 infection have abnormal liver function, and this is associated with longer hospital stay. A significantly higher proportion of patients with abnormal liver function had received lopinavir/ritonavir after admission; these drugs should be given with caution. Some patients with SARS-CoV-2 infection have abnormal liver function. We aimed to clarify the features of COVID-19-related liver damage to provide references for clinical treatment. We performed a retrospective, single-center study of 148 consecutive patients with confirmed COVID-19 (73 female, 75 male; mean age, 50 years) at the Shanghai Public Health Clinical Center from January 20 through January 31, 2020. Patient outcomes were followed until February 19, 2020. Patients were analyzed for clinical features, laboratory parameters (including liver function tests), medications, and length of hospital stay. Abnormal liver function was defined as increased levels of alanine and aspartate aminotransferase, gamma glutamyltransferase, alkaline phosphatase, and total bilirubin. Fifty-five patients (37.2%) had abnormal liver function at hospital admission; 14.5% of these patients had high fever (14.5%), compared with 4.3% of patients with normal liver function (P = .027). Patients with abnormal liver function were more likely to be male, and had higher levels of procalcitonin and C-reactive protein. There was no statistical difference between groups in medications taken before hospitalization; a significantly higher proportion of patients with abnormal liver function (57.8%) had received lopinavir/ritonavir after admission compared to patients with normal liver function (31.3%). Patients with abnormal liver function had longer mean hospital stays (15.09 ± 4.79 days) than patients with normal liver function (12.76 ± 4.14 days) (P = .021). More than one third of patients admitted to the hospital with SARS-CoV-2 infection have abnormal liver function, and this is associated with longer hospital stay. A significantly higher proportion of patients with abnormal liver function had received lopinavir/ritonavir after admission; these drugs should be given with caution." @default.
• W3015256585 created "2020-04-17" @default.
• W3015256585 creator A5011275179 @default.
• W3015256585 creator A5027835055 @default.
• W3015256585 creator A5028767805 @default.
• W3015256585 creator A5033559997 @default.
• W3015256585 creator A5039032916 @default.
• W3015256585 creator A5042329149 @default.
• W3015256585 creator A5055571226 @default.
• W3015256585 creator A5069841884 @default.
• W3015256585 creator A5077821208 @default.
• W3015256585 creator A5080336977 @default.
• W3015256585 date "2020-06-01" @default.
• W3015256585 modified "2023-10-11" @default.
• W3015256585 title "Clinical Features of COVID-19-Related Liver Functional Abnormality" @default.
• W3015256585 cites W1970784931 @default.
• W3015256585 cites W1985254748 @default.
• W3015256585 cites W2006434809 @default.
• W3015256585 cites W2074545478 @default.
• W3015256585 cites W2131262274 @default.
• W3015256585 cites W2136955892 @default.
• W3015256585 cites W2168950474 @default.
• W3015256585 cites W2913330242 @default.
• W3015256585 cites W3001118548 @default.
• W3015256585 cites W3001897055 @default.
• W3015256585 cites W3002108456 @default.
• W3015256585 cites W3003465021 @default.
• W3015256585 cites W3003668884 @default.
• W3015256585 cites W3004280078 @default.
• W3015256585 cites W3004662718 @default.
• W3015256585 cites W3005477624 @default.
• W3015256585 cites W3007940623 @default.
• W3015256585 cites W3008696669 @default.
• W3015256585 cites W3008818676 @default.
• W3015256585 cites W3009906937 @default.
• W3015256585 cites W3165656738 @default.
• W3015256585 doi "https://doi.org/10.1016/j.cgh.2020.04.002" @default.
• W3015256585 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7194865" @default.
• W3015256585 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32283325" @default.
• W3015256585 hasPublicationYear "2020" @default.
• W3015256585 type Work @default.
• W3015256585 sameAs 3015256585 @default.
• W3015256585 citedByCount "598" @default.
• W3015256585 countsByYear W30152565852019 @default.
• W3015256585 countsByYear W30152565852020 @default.
• W3015256585 countsByYear W30152565852021 @default.
• W3015256585 countsByYear W30152565852022 @default.
• W3015256585 countsByYear W30152565852023 @default.
• W3015256585 crossrefType "journal-article" @default.
• W3015256585 hasAuthorship W3015256585A5011275179 @default.
• W3015256585 hasAuthorship W3015256585A5027835055 @default.
• W3015256585 hasAuthorship W3015256585A5028767805 @default.
• W3015256585 hasAuthorship W3015256585A5033559997 @default.
• W3015256585 hasAuthorship W3015256585A5039032916 @default.
• W3015256585 hasAuthorship W3015256585A5042329149 @default.
• W3015256585 hasAuthorship W3015256585A5055571226 @default.
• W3015256585 hasAuthorship W3015256585A5069841884 @default.
• W3015256585 hasAuthorship W3015256585A5077821208 @default.
• W3015256585 hasAuthorship W3015256585A5080336977 @default.
• W3015256585 hasBestOaLocation W30152565851 @default.
• W3015256585 hasConcept C10936531 @default.
• W3015256585 hasConcept C118552586 @default.
• W3015256585 hasConcept C126322002 @default.
• W3015256585 hasConcept C160160445 @default.
• W3015256585 hasConcept C167135981 @default.
• W3015256585 hasConcept C181199279 @default.
• W3015256585 hasConcept C185592680 @default.
• W3015256585 hasConcept C2777513400 @default.
• W3015256585 hasConcept C2777969384 @default.
• W3015256585 hasConcept C2778384902 @default.
• W3015256585 hasConcept C2778606649 @default.
• W3015256585 hasConcept C2992208098 @default.
• W3015256585 hasConcept C50965678 @default.
• W3015256585 hasConcept C512861765 @default.
• W3015256585 hasConcept C55493867 @default.
• W3015256585 hasConcept C71924100 @default.
• W3015256585 hasConcept C90924648 @default.
• W3015256585 hasConceptScore W3015256585C10936531 @default.
• W3015256585 hasConceptScore W3015256585C118552586 @default.
• W3015256585 hasConceptScore W3015256585C126322002 @default.
• W3015256585 hasConceptScore W3015256585C160160445 @default.
• W3015256585 hasConceptScore W3015256585C167135981 @default.
• W3015256585 hasConceptScore W3015256585C181199279 @default.
• W3015256585 hasConceptScore W3015256585C185592680 @default.
• W3015256585 hasConceptScore W3015256585C2777513400 @default.
• W3015256585 hasConceptScore W3015256585C2777969384 @default.
• W3015256585 hasConceptScore W3015256585C2778384902 @default.
• W3015256585 hasConceptScore W3015256585C2778606649 @default.
• W3015256585 hasConceptScore W3015256585C2992208098 @default.
• W3015256585 hasConceptScore W3015256585C50965678 @default.
• W3015256585 hasConceptScore W3015256585C512861765 @default.
• W3015256585 hasConceptScore W3015256585C55493867 @default.
• W3015256585 hasConceptScore W3015256585C71924100 @default.
• W3015256585 hasConceptScore W3015256585C90924648 @default.
• W3015256585 hasIssue "7" @default.
• W3015256585 hasLocation W30152565851 @default.
• W3015256585 hasLocation W30152565852 @default.
• W3015256585 hasLocation W30152565853 @default.

• next